FDA
approval
· 2023-11-08
FDA Approved: ZEPBOUND — Original Application (Eli Lilly and Company)
Summary
The FDA approved ZEPBOUND (tirzepatide) from Eli Lilly through an original application for obesity/weight management in adults. This marks the drug's first appr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ZEPBOUND (TIRZEPATIDE)